Drug Trial Radar · NCT06475404
A Study of the Tolerance, Safety, and Pharmacokinetics of GNR-055 in Healthy Volunteers
Last checked: Nov 19, 2026Latest source record: Jul 3, 2024 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
18
Actual
Start
Apr 6, 2023
Primary completion
Sep 20, 2023
Study completion Sep 20, 2023
Sponsor
- Lead sponsor
- AO GENERIUMIndustry
- Sponsor type
- Industry
- First posted
- Jun 26, 2024
Design
- Study type
- Interventional
- Phase
- Phase 1
- Allocation
- Non randomized
- Model
- Sequential
- Masking
- None
- Primary purpose
- Other
- FDA-regulated drug
- No
- Who can join
- Male only, from 18 years, up to 45 years
- Healthy volunteers
- Yes
Summary
As written by the sponsor on the registry.
It is a phase I open-label single-dose, dose-escalation cohort study to evaluate of the tolerance, safety, and pharmacokinetics of GNR-055 in healthy volunteers
Conditions
- Mucopolysaccharidosis Type II
- Metabolic Diseases
Interventions
verenafusp alfa 6 mg/kgBiological
Single intravenous administration of 6 mg/kg of verenafusp alfa
verenafusp alfa 9 mg/kgBiological
Single intravenous administration of 9 mg/kg of verenafusp alfa
verenafusp alfa 12 mg/kgBiological
Single intravenous administration of 12 mg/kg of verenafusp alfa
Primary outcomes
What the sponsor says the trial is designed to measure.
- Proportion of participants with Adverse EventsTime frame: Day 28
Locations
1 site in 1 country. Site status is shown where the registry gives one.
State budgetary healthcare institution of the city of Moscow "City Clinic No. 2 of the Moscow Health Department"
Moscow, Russia
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.